Gestational Hypertension Clinical Trials
2 recruiting trials for Gestational Hypertension. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Gestational Hypertension clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Hasselt University (1), University of Alabama at Birmingham (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is supervised infrared exercise group (other, 1 trial), followed by supervised non-infrared exercise group, Control group.
Track Gestational Hypertension trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Physical Activity and Cardiovascular Profile of Pre-conceptional Women At Risk for GHD
To compare the cardiovascular profile of pre-conceptional women at risk for developing Gestational Hypertensive Disorders in subsequent pregnancy before and after physical...
The ACHIEVE Trial: Achieving Longer Gestation in Preeclampsia Via Antihypertensive Therapy.
The Achieve Trial is a randomized clinical trial to test whether lowering blood pressure to less than 140/90 mmHg in women with hypertensive disorders of pregnancy will prolong...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Gestational Hypertension, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Gestational Hypertension, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Gestational Hypertension, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.